Results 1 to 2 of 2

Thread: Lendlease to build large-scale Singapore vaccine facility in late-2021

  1. #1
    Join Date
    Oct 2011
    Posts
    10,829

    Default Lendlease to build large-scale Singapore vaccine facility in late-2021

    Lendlease to build large-scale Singapore vaccine facility in late-2021

    Oct 07, 2021

    SYDNEY-BASED Lendlease, which manages Singapore-listed Lendlease Global Commercial Reit, is commencing construction on a large-scale, greenfield vaccine facility in late-2021.

    The new facility will leverage the real estate group's digital capabilities, best practices in construction and experience in the sector, it said in a press statement on Thursday. It added that it has built more than 90 per cent of the biotechnology facilities in JTC's Tuas Biomedical Park since the late-1990s.

    Lendlease has also been appointed to take on additional projects for existing Singapore clients, including expanding existing facilities to enhance their capabilities.

    Lendlease Asia chief executive Justin Gabbani said the life sciences sector is one of the group's key focus areas where it is looking to apply its expertise across the integrated real estate value chain.

    In March 2021, Lendlease inked a partnership in the US with institutional investor Ivanhoe Cambridge to develop the 60 Guest Street project in Boston, a 320,000 square foot life sciences hub.

  2. #2
    Join Date
    Aug 2020
    Posts
    1,740

    Default Re: Lendlease to build large-scale Singapore vaccine facility in late-2021

    Lendlease to build large-scale Singapore vaccine facility in late-2021

    Oct 08, 2021

    SYDNEY-BASED Lendlease, which manages Singapore-listed Lendlease Global Commercial Reit, is commencing construction on a large-scale, greenfield vaccine facility in late-2021.

    It did not disclose the identity of the client.

    The move comes as the Republic sees an increase in the number of Covid-19 vaccine-related investments, with three major pharmaceutical companies - BioNTech, Sanofi and Thermo Fisher Scientific - having plans to set up vaccine manufacturing facilities here.

    The new facility will leverage the real estate group's digital capabilities, best practices in construction and experience in the sector, it said in a press statement on Thursday. It added that it has built more than 90 per cent of the biotechnology facilities in JTC's Tuas Biomedical Park since the late-1990s.

    Lendlease has also been appointed to take on additional projects for existing Singapore clients, including expanding existing facilities to enhance their capabilities.

    Lendlease Asia chief executive Justin Gabbani said the life sciences sector is one of the group's key focus areas where it is looking to apply its expertise across the integrated real estate value chain.

    In March 2021, Lendlease inked a partnership in the US with institutional investor Ivanhoe Cambridge to develop the 60 Guest Street project in Boston, a 320,000 square foot life sciences hub.

Similar Threads

  1. Covid-19 vaccine may only be available in end-2021: MOH
    By Unregistered1234 in forum Coffeeshop Talk
    Replies: 0
    -: 26-07-20, 18:20
  2. Covid-19 vaccine unlikely ready until early 2021: WHO
    By reporter2 in forum Coffeeshop Talk
    Replies: 0
    -: 24-07-20, 12:27
  3. Mapletree to build $250m multi-use facility in Tai Seng
    By reporter2 in forum HDB, EC, commercial and industrial property discussion
    Replies: 0
    -: 27-12-13, 15:51
  4. Large Scale Demonstrations Are Happening in China
    By richwang in forum Coffeeshop Talk
    Replies: 1
    -: 19-08-12, 18:24
  5. Get set for flood of large-scale launches
    By mr funny in forum Singapore Private Condominium Property Discussion and News
    Replies: 0
    -: 08-01-07, 13:32

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •